Project Grant HT94252410045
Award Date
3/1/24
Completion Date
2/28/27
Dollars Obligated
$1.6M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Houston, TX 77030, USA
Similar Awards
Baylor College of Medicine will use a $1.56 million project grant from the Defense Health Agency to research germline variants and population-wide breast cancer risk. The grant was awarded on February 1, 2023 under the Military Medical Research and Development program (CFDA 12.420). Through this four-year award, Baylor College of Medicine will investigate medical solutions for breast cancer through innovative and impactful research aimed at transforming health care for service members and the...
The federal Project Grant award of $1,597,224.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program to support the research project "BCL-XL IN BREAST CANCER METASTASIS AND THERAPY" at Baylor College of Medicine in Houston, Texas. The award, with a performance period from August 1, 2024 to July 31, 2027, will fund advanced biomedical research initiatives focused on transforming healthcare for military service...
This federal Project Grant award of $2,239,998.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by Baylor College of Medicine to investigate the progression from ductal carcinoma in situ (DCIS) to invasive basal-like breast cancer driven by the N-RAS gene. The research project aims to advance the understanding of this disease process with the potential to lead to improved diagnostic and treatment approaches. The award...
The Baylor College of Medicine will use a $1.6 million Project Grant from the Defense Health Agency to research germline variants and population-wide breast cancer risk. The grant was awarded on February 1, 2023 under the Military Medical Research and Development program (CFDA 12.420). Through basic, applied, and advanced biomedical research, this project aims to transform healthcare for service members and the public by investigating medical solutions for the battlefield and developing...
This $1,200,000 federal Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by Baylor College of Medicine to develop a bone-targeting E-cadherin antibody nanogel for eliminating bone metastases. The 3-year award, running from April 1, 2025 to March 31, 2028, will fund advanced biomedical research initiatives focused on transforming healthcare for military service members and the general public through...
This $1,200,000.00 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award will fund Baylor College of Medicine to conduct research on precision glycocalyx editing of the metastatic bone microenvironment over a three-year period from September 15, 2023 to September 14, 2026. As a private non-profit university, Baylor College of Medicine has extensive experience managing federal grants and contracts for biomedical...
This Defense Health Agency Project Grant award of $1,225,878.00 to Baylor College of Medicine, granted under the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420), is investigating the use of nebivolol, a beta-blocker medication, as a potential treatment for triple-negative breast cancer. The research project, which runs from January 1, 2024 to December 31, 2026, aims to advance scientific understanding and develop new treatment options for this...
The Baylor College of Medicine will leverage spliceosome-targeted therapies to harness the immune system against metastatic breast cancer under a $800,000 Project Grant from the Department of the Army Medical Command. The grant is part of the Military Medical Research and Development program, with the CFDA number 12.420, which supports basic, applied, and advanced biomedical research to transform military and public health care through innovative medical solutions for battlefield injuries and...
The Defense Health Agency awarded a $784,602 Project Grant to Dana-Farber Cancer Institute, Inc. (doing business as Dfci) under the Military Medical Research and Development program (CFDA 12.420). The grant will support research from January 2023 to January 2026 to develop next-generation immunotherapy for breast cancer by turning breast cancer cells against themselves. The Military Medical Research and Development program aims to transform military and public health through innovative medical...
The Department of the Army Medical Command awarded a $1,065,567 project grant to Baylor College of Medicine to develop a novel therapeutic strategy for prostate cancer in African American men. The grant was awarded under the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform military and public health care through innovative and impactful medical solutions. Funding will support Baylor College of Medicine's...